Hyperprolactinemia: Clinical Trials

4 trials for Hyperprolactinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 2, Completed 1, Unknown 1

Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Cabergoline - Prolactinoma, Prolactin Excess
Phase 3RecruitingUniversity of Sao Paulo General Hospital702026-03-042026-03-13
A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets
Cabergoline tablets, Bromocriptine mesylate tablets - Hyperprolactinemia
Phase 3RecruitingChangchun GeneScience Pharmaceutical Co., Ltd.3822025-09-122025-10-02
Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Calcium and Vitamin D, Placebo - Risperidone-induced Hyperprolactinemia
Phase 3CompletedChadi A. Calarge472008-11-012017-12-26
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
Bromocriptin - Schizophrenia, Hyperprolactinemia
Phase 3UnknownUniversity Hospital, Bonn202006-05-012006-04-17

Narrower conditions

Prolactinoma (1)  ·  Schizophrenia (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Endocrine System Diseases (4)  ·  Hyperpituitarism (4)  ·  Hypothalamic Diseases (4)  ·  Nervous System Diseases (4)  ·  Pituitary Diseases (4)  ·  Adenoma (1)  ·  Endocrine Gland Neoplasms (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Pituitary Neoplasms (1)

Interventions

Bromocriptine (2)  ·  Cabergoline (2)  ·  Calcium (1)  ·  Vitamin D (1)

Sponsors

Chadi A. Calarge (1)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (1)  ·  University Hospital, Bonn (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (1)  ·  China (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Chadi Calarge, M.D. (1)  ·  Wolfgang Maier, MD (1)

Results publications

PMID 29112461

NIH funding

K23MH085005 (1)